# Safety and Efficacy of Hydroxychloroquine for the Treatment & Prevention of Coronavirus Disease 2019 (COVID-19) Caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)

> **NCT04590274** · PHASE1 · WITHDRAWN · sponsor: **International Brain Research Foundation**

## Conditions studied

- Covid19
- SARS (Severe Acute Respiratory Syndrome)

## Interventions

- **DRUG:** Hydroxychloroquine
- **DIETARY_SUPPLEMENT:** Vitamins and Minerals
- **DRUG:** Azithromycin

## Key facts

- **NCT ID:** NCT04590274
- **Lead sponsor:** International Brain Research Foundation
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2020-11
- **Primary completion:** 2021-12
- **Final completion:** 2021-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Investigative Team no longer interested
- **Last updated:** 2021-12-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04590274

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04590274, "Safety and Efficacy of Hydroxychloroquine for the Treatment & Prevention of Coronavirus Disease 2019 (COVID-19) Caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT04590274. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*